Company Data
CNS Pharmaceuticals Inc.
Ticker
CNSP
Current Price
$0.075 -10.5%
Market Cap
$4.3M
Price Target
Refer to Report
Volume
35.4M
52wk Range
$0.0803 - $1195
Overview
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.